Use of percutaneous microwave ablation in the treatment of retroperitoneal neoplasia in three dogs
| Autor: | Eric G. Johnson, Carrie A. Palm, Craig B. Glaiberman, Jenna H Burton, Robert B. Rebhun, William T. N. Culp, Michael S. Kent, Carlos O. Rodriguez |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Percutaneous General Veterinary business.industry Microwave ablation Ultrasound Kidney Neoplasms Diaphragm (structural system) medicine.anatomical_structure Dogs Treatment Outcome medicine Renal mass Catheter Ablation Retroperitoneal space Animals Clinical significance Radiology Dog Diseases Retroperitoneal Space Image guidance business Microwaves Tomography X-Ray Computed |
| Zdroj: | Journal of the American Veterinary Medical Association. 259(10) |
| ISSN: | 1943-569X |
| Popis: | CASE DESCRIPTION 3 dogs with retroperitoneal masses (2 renal and 1 located near the diaphragm) were treated by percutaneous microwave ablation (MWA). CLINICAL FINDINGS Dogs between 11 and 13 years of age weighing between 13.7 and 43.8 kg had either a renal mass (n = 2) or a mass located in the caudodorsal aspect of the retroperitoneal space near the right side of the diaphragm (1). Cytology revealed that one of the renal masses and the mass located near the diaphragm were malignant neoplasias. Findings on cytologic evaluation of a sample of the other renal mass was nondiagnostic. Maximum mass diameters ranged between 1.4 and 2.5 cm. TREATMENT AND OUTCOME All dogs were treated by percutaneous MWA. Probes were directed into tumors by use of ultrasound and CT guidance, and microwave energy was applied to each mass. Findings on imaging of each mass following MWA was consistent with successful treatment. No intraprocedural or major postprocedural complications occurred, and all dogs were discharged from the hospital within 3 days of treatment. Two dogs died at 3 and 21 months after MWA with no known local recurrence; 1 dog was still alive 64 months after treatment. CLINICAL RELEVANCE Although the indications for MWA in the treatment of neoplasia in companion animals are limited, the outcomes of dogs in the present report provided preliminary evidence that percutaneous MWA can be safely used to effectively treat retroperitoneal neoplasia. This procedure was successfully performed with image guidance in all 3 dogs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|